🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

3,061 results for “Bio” Clear

  1. Zimberelimab

    Arcus Biosciences

    Melanoma

    phase 2 small molecule active

    1 trial

  2. Zimberelimab

    Arcus Biosciences

    Pancreatic Ductal Adenocarcinoma

    phase 2 small molecule active

    1 trial

  3. Zimberelimab

    Arcus Biosciences

    Adenocarcinoma Stomach

    phase 2 small molecule terminated

    1 trial

  4. Zimberelimab (ZIM)

    Arcus Biosciences

    Lung Cancer

    phase 2 small molecule active

    1 trial

  5. Zydena (Udenafil)

    Samsung Bioepis NL B.V.

    Vascular Dementia

    phase 2 small molecule active

    1 trial

  6. acetylsalicylic acid

    Protalix BioTherapeutics

    Upper Gastrointestinal Mucosal Damage

    phase 2 small molecule completed

    1 trial

  7. aerobic exercise

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 other completed

    1 trial

  8. affect regulation training

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 2 other completed

    1 trial

  9. alprazolam

    BRIGHT MINDS BIOSCIENCES INC.

    Anxiety Disorder

    phase 2 small molecule completed

    1 trial

  10. atomoxetine

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 2 small molecule completed

    1 trial

  11. autologous dendritic cells pulsed with tumor lysate antigen Vaccine

    NORTHWEST BIOTHERAPEUTICS INC

    Giant Cell Glioblastoma

    phase 2 mab terminated

    1 trial

  12. avelumab

    Samsung Bioepis NL B.V.

    Lymphoma, Extranodal NK-T-Cell

    phase 2 small molecule active

    1 trial

  13. bezuclastinib

    Cogent Biosciences

    Advanced Systemic Mastocytosis (AdvSM)

    phase 2 small molecule active

    1 trial

  14. buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    phase 2 small molecule active

    1 trial

  15. buprenorphine taper followed by naltrexone maintenance

    BRIGHT MINDS BIOSCIENCES INC.

    Prescription Opioid Dependence

    phase 2 small molecule completed

    1 trial

  16. chantix

    BRIGHT MINDS BIOSCIENCES INC.

    Varenicline and the Blunting of Cocaine Cues

    phase 2 small molecule terminated

    1 trial

  17. chatbot

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate-Related Disorders

    phase 2 other active

    1 trial

  18. citicoline

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Abuse

    phase 2 small molecule completed

    1 trial

  19. clarithromycin

    BRIGHT MINDS BIOSCIENCES INC.

    Relapse/Refractory Multiple Myeloma

    phase 2 small molecule terminated

    1 trial

  20. coformulated emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) as PrEP

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 2 small molecule completed

    1 trial

  21. controlled release carvedilol

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    1 trial

  22. d-cycloserine

    BRIGHT MINDS BIOSCIENCES INC.

    Panic Disorder

    phase 2 small molecule completed

    1 trial

  23. d-cycloserine

    BRIGHT MINDS BIOSCIENCES INC.

    COCAINE-RELATED DISORDERS

    phase 2 small molecule completed

    1 trial

  24. delolimogene mupadenorepvec

    Chongqing Precision Biotech Co., Ltd

    Malignant Melanoma

    phase 2 gene therapy completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources